Artificial intelligence and its role in guiding liverdirected therapy for hepatocellular carcinoma:Is it ready for prime time?
作者机构：Hepatobiliary Surgery UnitFondazione Policlinico Universitario Agostino Gemelli IRCCSUniversitàCattolica del Sacro CuoreRome 00168Italy Emergency and Trauma Surgery UnitFondazione Policlinico Universitario Agostino Gemelli IRCCSUniversitàCattolica del Sacro CuoreRome 00168Italy
出 版 物：《Hepatoma Research》 (肝癌研究（英文版）)
年 卷 期：2022年第8卷第1期
页 面：466-481页
学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
主 题：Artificial intelligence precision medicine HCC hepatocellular carcinoma
摘 要：Artificial intelligence(AI)is an innovative discipline in medicine,impacting both hepatology and hepato-pancreatobiliary surgery,ensuring reliable outcomes because of its repeatable and efficient algorithms.A considerable number of studies about the efficiency of AI in the management of hepatocellular carcinoma(HCC)have been *** its diagnostic role is well recognized,providing large amounts of quantitative radiological HCC features,its use in HCC treatment is still *** use of AI may help to select the best approach for each patient as it is able to predict the outcomes after resection and/or other *** this review,we assess the role of AI in selecting the best therapeutic option and predicting long-term risks after surgical or interventional treatments for HCC *** studies are needed to consolidate AI applications.
维普期刊数据库